| Gene symbol | GPRC5D | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | G protein-coupled receptor class C group 5 member D | ||||
| GTO ID | GTC3362 |
| Trial ID | NCT05759793 |
| Disease | Multiple Myeloma | Plasma Cell Leukemia |
| Altered gene | GPRC5D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPRC5D CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia |
| Year | 2023 |
| Country | China |
| Company sponsor | Nanjing IASO Biotherapeutics Co., Ltd |
| Other ID(s) | RD138CI002 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||